Hugo W. Moser Research Institute at Kennedy Krieger, Inc.   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Baltimore MD United States (1937)

Organization Overview

First Clinical Trial
1997
NCT00005014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anne Comi, MD | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Kathryn Wagner | KKI/JH